These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7809341)

  • 21. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
    J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
    Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of endogenous opioids in neurohypophysial and hypothalamo-pituitary-adrenal axis hormone secretory responses to stress in pregnant rats.
    Douglas AJ; Johnstone HA; Wigger A; Landgraf R; Russell JA; Neumann ID
    J Endocrinol; 1998 Aug; 158(2):285-93. PubMed ID: 9771473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L
    ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premenstrual syndrome is associated with blunted cortisol reactivity to the TSST.
    Huang Y; Zhou R; Wu M; Wang Q; Zhao Y
    Stress; 2015; 18(2):160-8. PubMed ID: 25518868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and environmental factors influence the hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone infusion in offspring of mothers with or without mood disorders.
    Ronsaville DS; Municchi G; Laney C; Cizza G; Meyer SE; Haim A; Radke-Yarrow M; Chrousos G; Gold PW; Martinez PE
    Dev Psychopathol; 2006; 18(1):173-94. PubMed ID: 16478558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
    Zis AP; Haskett RF; Albala AA; Carroll BJ; Lohr NE
    Arch Gen Psychiatry; 1985 Apr; 42(4):383-6. PubMed ID: 3977556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
    Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of corticotropin-releasing hormone testing in assessment of hypothalamic-pituitary-adrenal axis function in infants with congenital central hypothyroidism.
    van Tijn DA; de Vijlder JJ; Vulsma T
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3794-803. PubMed ID: 18647808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia.
    Wolkowitz OM; Doran AR; Breier A; Cohen MR; Pickar D
    Biol Psychiatry; 1986 Apr; 21(4):366-73. PubMed ID: 2869791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence.
    Zhang GF; Ren YP; Sheng LX; Chi Y; Du WJ; Guo S; Jiang ZN; Xiao L; Luo XN; Tang YL; Smith AK; Liu ZQ; Zhang HX
    Am J Drug Alcohol Abuse; 2008; 34(6):760-8. PubMed ID: 19016181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity of the hypothalamic-pituitary-adrenal axis to naloxone in post-traumatic stress disorder.
    Hockings GI; Grice JE; Ward WK; Walters MM; Jensen GR; Jackson RV
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):585-93. PubMed ID: 8392385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A psychoendocrine study of premenstrual tension syndrome. A model for endogenous depression?
    Haskett RF; Steiner M; Carroll BJ
    J Affect Disord; 1984 Apr; 6(2):191-9. PubMed ID: 6233351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls.
    Michelson D; Altemus M; Galliven E; Hill L; Greenberg BD; Gold P
    Neuropsychopharmacology; 1996 Aug; 15(2):207-12. PubMed ID: 8840357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man.
    Grossman A; Moult PJ; Cunnah D; Besser M
    Neuroendocrinology; 1986; 42(4):357-60. PubMed ID: 3008020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.